These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27076245)

  • 1. [Diagnosis and treatment of heparin-induced thrombocytopenia (HIT) based on its atypical immunological features].
    Miyata S; Maeda T
    Rinsho Ketsueki; 2016 Mar; 57(3):322-32. PubMed ID: 27076245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Spontaneous heparin-induced thrombocytopenia (HIT) syndrome: HIT without any heparin exposure].
    Miyata S
    Rinsho Ketsueki; 2016; 57(10):2124-2135. PubMed ID: 27795522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unique immunological features of heparin-induced thrombocytopenia.
    Staibano P; Arnold DM; Bowdish DM; Nazy I
    Br J Haematol; 2017 Apr; 177(2):198-207. PubMed ID: 28369702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
    Lo GK; Sigouin CS; Warkentin TE
    Am J Hematol; 2007 Dec; 82(12):1037-43. PubMed ID: 17722079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing for heparin-induced thrombocytopenia antibodies.
    Warkentin TE; Sheppard JA
    Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How I diagnose and manage HIT.
    Warkentin TE
    Hematology Am Soc Hematol Educ Program; 2011; 2011():143-9. PubMed ID: 22160026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia.
    Althaus K; Hron G; Strobel U; Abbate R; Rogolino A; Davidson S; Greinacher A; Bakchoul T
    Thromb Res; 2013 Mar; 131(3):e85-90. PubMed ID: 23351665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia.
    Fabris F; Luzzatto G; Stefani PM; Girolami B; Cella G; Girolami A
    Haematologica; 2000 Jan; 85(1):72-81. PubMed ID: 10629596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology and laboratory testing of heparin-induced thrombocytopenia.
    Chong BH; Eisbacher M
    Semin Hematol; 1998 Oct; 35(4 Suppl 5):3-8; discussion 35-6. PubMed ID: 9855178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia: diagnosis and management.
    Hassell K
    Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies.
    Selleng K; Warkentin TE; Sheppard JA; Greinacher A
    Transfusion; 2009 Sep; 49(9):1812-8. PubMed ID: 19497062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous heparin-induced thrombocytopenia syndrome without any proximate heparin exposure, infection, or inflammatory condition: Atypical clinical features with heparin-dependent platelet activating antibodies.
    Okata T; Miyata S; Miyashita F; Maeda T; Toyoda K
    Platelets; 2015; 26(6):602-7. PubMed ID: 25383922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
    Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
    J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of acute systemic reaction and detection of IgG antibodies against PF4/heparin complexes in hemodialysis patients.
    Matsuo T; Wanaka K; Miyasita K; Prechel M; Walenga JM
    Thromb Res; 2012 Apr; 129(4):474-8. PubMed ID: 22088491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The approach to heparin-induced thrombocytopenia.
    Linkins LA; Warkentin TE
    Semin Respir Crit Care Med; 2008 Feb; 29(1):66-74. PubMed ID: 18302088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of heparin-induced thrombocytopenia.
    Jaax ME; Greinacher A
    Expert Opin Pharmacother; 2012 May; 13(7):987-1006. PubMed ID: 22475438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of heparin-induced thrombocytopenia.
    Cosmi B
    Expert Rev Hematol; 2015 Dec; 8(6):837-49. PubMed ID: 26368591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current insights into the laboratory diagnosis of HIT.
    Bakchoul T; Zöllner H; Greinacher A
    Int J Lab Hematol; 2014 Jun; 36(3):296-305. PubMed ID: 24750676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.